Vivo Bio Tech Ltd. (VIVOBIOT) Share Price Falls 11.5% Amid Market Volatility

Updated: 29 Jul 2026 • 11:58 am

Posted by:

Vivo Bio Tech Ltd. (VIVOBIOT) Share Price Falls 11.5% Amid Market Volatility

Vivo Bio Tech Ltd. Share Price experienced a significant decline today, falling by 11.5% to close at Rs 20. This drop brings the company's market capitalisation to Rs 50.73 crore. The decline in share price is notable within the micro-cap category, where such movements can have a pronounced impact on investor sentiment. The data confirms the price fall but does not establish a company-specific catalyst for this movement.

The stock opened at Rs 22.94 and reached a high of the same value before declining to a low of Rs 18.36 during the trading session. The total turnover for the day was Rs 0.15 crore, with a volume of 75,369 shares traded on the BSE. This level of activity indicates a heightened interest in the stock, possibly driven by broader market conditions or sector-specific factors.

Table of Contents

Vivo Bio Tech Ltd. (VIVOBIOT) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 20
Previous Close	Rs 22.6
Today's Change	Rs -2.6 (-11.5%)
Day Open	Rs 22.94
Day High	Rs 22.94
Day Low	Rs 18.36
Current Volume (BSE)	75,369
BSE Traded Volume	75,369
Combined NSE + BSE Volume	75,369
Turnover	Rs 0.15 crore
Market Capitalisation	Rs 50.73 crore
Market Cap Category	Micro Cap

Vivo Bio Tech Ltd. (VIVOBIOT) traded at Rs 20. versus the previous close of Rs 22.6, a fall of 11.5%. The stock opened at Rs 22.94, reached Rs 22.94, touched Rs 18.36. Reported volume was 75,369.

Vivo Bio Tech Ltd. (VIVOBIOT) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 50.73 crore
P/E Ratio	-15.5x
P/B Ratio	0.55x
ROE	15.36%
ROCE	18.81%
EPS	Rs -1.29
Dividend Yield	0%

Vivo Bio Tech Ltd. was valued at a P/E ratio of -15.5x, a P/B ratio of 0.55x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 15.36% and ROCE of 18.81%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs -1.29, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	-15.5x
Benchmark Median P/E	26.37x
Benchmark Average P/E	80.74x
Benchmark P/E Range	3.61x to 3,439.3x
Company P/B Ratio	0.55x
Benchmark Median P/B	1.82x
Company ROE	15.36%
Benchmark Median ROE	10.31%
Company ROCE	18.81%
Benchmark Median ROCE	12.96%
Company Market Capitalisation	Rs 50.73 crore
Benchmark Median Market Cap	Rs 147.71 crore

Vivo Bio Tech Ltd. (VIVOBIOT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs. The numerical benchmark uses 137 same industry companies from the supplied master-data set.

Vivo Bio Tech Ltd. (VIVOBIOT) has a P/E ratio of -15.5x, which is below the benchmark median of 26.37x, a difference of -158.78%. The benchmark contains 103 companies with P/E data, ranging from 3.61x to 3,439.3x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Vivo Bio Tech Ltd. (VIVOBIOT) has a ROE of 15.36%, which is above the benchmark median of 10.31%, a difference of +48.98%. Vivo Bio Tech Ltd. (VIVOBIOT) has a ROCE of 18.81%, which is above the benchmark median of 12.96%, a difference of +45.14%.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,921.65	29.31	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,815.27	39.89	8.12	28.21	26.35
Hikal Ltd.	HIKAL	2,738.51	0	2.23	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,653.99	0	3.04	0	5.36
Sai Parenteral's Ltd.	SAIPARENT	2,476.69	169.37	3.13	13.9	12.97

Vivo Bio Tech Ltd. (VIVOBIOT) has a P/E ratio of -15.5x compared with the displayed peer median of 29.31x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.36% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 18.81% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Vivo Bio Tech Ltd. (VIVOBIOT) has a market capitalisation of Rs 50.73 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Vivo Bio Tech Ltd.

Investors are closely monitoring Vivo Bio Tech Ltd. due to its recent price action and market position. The company's technical and fundamental metrics provide insights into its potential trajectory.

Price Action: Significant 11.5% decline today.
Technical Position: RSI indicates neutral momentum.
Fundamental Context: Negative P/E but strong ROE and ROCE.
Sector Positioning: Operates within the dynamic Healthcare sector.

Investors should continue to monitor Vivo Bio Tech Ltd.'s market movements, technical indicators, and sector trends to better understand its potential future performance.

About Vivo Bio Tech Ltd.

Vivo Bio Tech Ltd. operates in the Pharmaceuticals & Drugs industry, providing a range of healthcare solutions. The company focuses on developing innovative products and services to meet the growing demands of the healthcare sector. Its operations are primarily centered around research and development, manufacturing, and distribution of pharmaceutical products.

As a micro-cap company, Vivo Bio Tech Ltd. faces unique challenges and opportunities within the industry. Its focus on innovation and efficiency positions it as a potential value play for investors seeking exposure to the healthcare sector. The company's ability to leverage its strengths and navigate industry trends will be crucial to its long-term success.

Track Vivo Bio Tech Ltd. Share Price on Univest

Use Vivo Bio Tech Ltd. (VIVOBIOT) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors can track Vivo Bio Tech Ltd. Share Price and access a wealth of market data on Univest. The platform provides live share prices, technical indicators, fundamental ratios, shareholding patterns, and market insights. Stay informed about Vivo Bio Tech Ltd.'s performance and make data-driven investment decisions with Univest's comprehensive tools and resources.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What caused Vivo Bio Tech Ltd. Share Price to fall today?

Ans. Vivo Bio Tech Ltd. Share Price fell 11.5% today, closing at Rs 20. The data confirms the price fall but does not establish a company-specific catalyst for this movement. The stock moved -11.5% during the session.

How did Vivo Bio Tech Ltd. perform in today's trading session?

Ans. Vivo Bio Tech Ltd. opened at Rs 22.94, hit a high of Rs 22.94, and a low of Rs 18.36, closing at Rs 20 with a turnover of Rs 0.15 crore.

What is Vivo Bio Tech Ltd.'s market capitalisation?

Ans. Vivo Bio Tech Ltd.'s market capitalisation is Rs 50.73 crore, categorising it as a micro-cap company within the Healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is -15.5x.

What is Vivo Bio Tech Ltd.'s P/E ratio? What is Vivo Bio Tech Ltd.'s ROE?

Ans. Vivo Bio Tech Ltd. has a Return on Equity (ROE) of 15.36%, which is above the industry median of 10.31%, indicating efficient capital use. ROE stands at 15.36%. ROCE stands at 18.81%.

How does Vivo Bio Tech Ltd.'s P/B ratio compare to the industry?

Ans. Vivo Bio Tech Ltd.'s P/B ratio is 0.55, below the industry median of 1.82, suggesting potential undervaluation or market skepticism. The company trades at a P/E ratio of -15.5x. Its P/B ratio is 0.55x.

How does Vivo Bio Tech Ltd. compare to its peers?

Ans. Vivo Bio Tech Ltd. has a lower market cap and P/E ratio compared to peers like Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.

What sector does Vivo Bio Tech Ltd. operate in?

Ans. Vivo Bio Tech Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry, focusing on innovative healthcare solutions. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.

What is Vivo Bio Tech Ltd.'s ROCE?

Ans. Vivo Bio Tech Ltd. has a Return on Capital Employed (ROCE) of 18.81%, above the industry median of 12.96%, indicating strong operational efficiency. ROE stands at 15.36%. ROCE stands at 18.81%.